A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

Local Institution - 0024, Taipei

Local Institution - 0031, Taipei

Local Institution - 0034, Lausanne

Local Institution - 0041, Herlev

Local Institution - 0033, Chur

Local Institution - 0012, New York

Local Institution - 0005, New York

Local Institution - 0009, Pittsburgh

Local Institution - 0006, Philadelphia

Local Institution - 0001, Baltimore

Local Institution - 0019, Madrid

Local Institution - 0020, Madrid

Florida Cancer Specialists - North, St. Petersburg

Florida Cancer Specialists - South, Fort Myers

Tennessee Oncology Chattanooga, Nashville

Washington University, St Louis

Local Institution - 0029, Mannheim

Local Institution - 0032, Heidelberg

Local Institution - 0013, Dallas

Local Institution - 0011, Houston

University Of Colorado, Aurora

Mayo Clinic in Rochester, Minnesota, Phoenix

HonorHealth Research Institute, Scottsdale

Universitaetsklinikum Ulm, Ulm

Local Institution - 0007, Los Angeles

Local Institution - 0030, Würzburg

University Of Washington, Seattle

Local Institution - 0022, Chuo-ku

Local Institution - 0023, Kashiwa-shi

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute., Boston

Local Institution - 0010, Boston

Cross Cancer Institute, Edmonton

Local Institution - 0037, Kingston

Local Institution - 0035, Toronto

Local Institution - 0025, Padua

Local Institution - 0026, Roma

Local Institution - 0018, Seoul

Local Institution - 0017, Seoul

Local Institution - 0021, Barcelona

Local Institution - 0016, Glasgow